Mycophenolate mofetil Terminated Phase 3 Trials for Cardiovascular Heart Disease / Transplantation, Kidney Prevention

IndicationsStatusPurposePhase
TerminatedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01213394Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients